Aug 14, 2019 CLR 131 Advances to Second Malignant Brain Tumor Cohort of Ongoing Pediatric Phase 1 Study Learn More
Aug 12, 2019 Cellectar Reports Second Quarter 2019 Financial Results and Provides a Corporate Update Learn More
Jul 9, 2019 Cellectar Receives FDA Fast Track Designation for CLR 131 in Diffuse Large B-Cell Lymphoma Learn More